Preventing Metastasis To 'Stop Cancer From Killing People'

Preventing Metastasis To 'Stop Cancer From Killing People'
Metastasis is the ability of cancer cells to spread from a primary site, to form tumours at distant sites. It is a complex process in which cell motility and invasion play a fundamental role. Essential to our understanding of how metastasis develops is identification of the molecules, and characterisation of the mechanisms that regulate cell motility. Hitherto, these mechanisms have been poorly understood.

Clatterbridge Centre For Oncology Ranked As One Of The Best Healthcare Organisations To Work For In The UK
Clatterbridge Centre for Oncology is one of the Top 100 healthcare organisations to work for in the UK according to a survey by the Health Service Journal. The survey asked employees at the Centre a range of questions and the Centre has been included in the Top 100 list! The final results will be announced in March 2009, when the Centre will find out where they came in the top 100.

East Surrey Hospital Reports Cases Of Winter Vomiting Virus, England
Holmwood and Godstone wards have been closed to incoming patients after 18 people at the hospital have developed symptoms of winter vomiting virus. Tests are now being done to find the cause and the wards will remain shut until all symptoms of the bug have cleared. Members of the public are being asked to consider the necessity of their visit to the hospital. No one should visit if they themselves have been unwell within the last week.

Tau Protein Expression Predicts Breast Cancer Survival -- Though Not As Expected
Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M. D. Anderson Cancer Center. Presented Dec. 13, at the CRTC-AACR San Antonio Breast Cancer Symposium, the researchers found that Tau expression does predict survival, yet in an unexpected way. In earlier neoadjuvant studies, investigators from M. D.

Low Income Men Diagnosed More Often With Advanced Prostate Cancer, The Journal Of Urology
Coincident with the widespread adoption of PSA screening, the proportion of American men diagnosed with organ-confined, low risk prostate cancer has increased significantly during the last two decades. In a study scheduled for publication in the February 2009 issue of

Possible Therapeutic Target For Pancreatic Cancer
A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

ABRAXANE In Combination With Gemcitabine And Epirubicin Evaluated As Neoadjuvant Treatment For Patients With Locally Advanced Breast Cancer
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of preliminary results from a single-arm, open-label, Phase II clinical trial evaluating ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin- bound) in combination with gemcitabine and epirubicin for the treatment of patients with locally advanced breast cancer (neoadjuvant treatment).

Study Finds That Low-Income Men Are More Likely To Be Diagnosed With Advanced Prostate Cancers
Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found. The study focused on a group of disadvantaged men enrolled in the state's IMPACT (Improving Access, Counseling and Treatment for Californians with Prostate Cancer) program, which provides high-quality care to poor, underinsured and uninsured men.